1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsLOI due March 16, 2026; full application (invited only) due June 16, 2026
PCF TACTICAL (Therapy ACceleration To Intercept CAncer Lethality) Awards is sponsored by Prostate Cancer Foundation (PCF). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Therapy ACceleration To Intercept CAncer Lethality Awards | Prostate Cancer Foundation Therapy ACceleration To Intercept CAncer Lethality Awards > Our Work > The Work We Fund > Therapy ACceleration To Intercept CAncer Lethality Awards PCF Research Awards Notification: Therapy ACceleration To Intercept CAncer Lethality Awards provide up to $10 million over three years to support large scale research projects led by qualified teams of academic scientists that specifically address the development of 21st Century therapies for lethal forms of prostate cancer.
“TACTICAL Awards bring together a team of teams to discover transformational breakthroughs that will help end death and suffering from prostate cancer. ” PCF Chief Medical Officer The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes.
Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes. Manage {vendor_count} vendors
According to the current listing, eligibility includes: Qualified teams of academic scientists. Confirm the full requirements in the official notice before applying.
PCF TACTICAL (Therapy ACceleration To Intercept CAncer Lethality) Awards is funded by Prostate Cancer Foundation (PCF). Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article